|
1
|
Haller H, Mamula O, Krasevic M, Rupcic S,
Fischer AB, Eminovic S, Manestar M and Perovic D: Frequency and
distribution of lymph node metastases in epithelial ovarian cancer.
Int J Gynecol Cancer. 21:245–250. 2011.PubMed/NCBI
|
|
2
|
Takeshima N, Hirai Y, Umayahara K,
Fujiwara K, Takizawa K and Hasumi K: Lymph node metastasis in
ovarian cancer: Difference between serous and non-serous primary
tumors. Gynecol Oncol. 99:427–431. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Panici PB, Maggioni A, Hacker N, Landoni
F, Ackermann S, Campagnutta E, Tamussino K, Winter R, Pellegrino A,
Greggi S, et al: Systematic aortic and pelvic lymphadenectomy
versus resection of bulky nodes only in optimally debulked advanced
ovarian cancer: A randomized clinical trial. J Natl Cancer Inst.
97:560–566. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Pereira A, Pérez-Medina T, Magrina JF,
Magtibay PM, Millan I and Iglesias E: The role of lymphadenectomy
in node-positive epithelial ovarian cancer. Int J Gynecol Cancer.
22:987–992. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Prat J: FIGO Committee on Gynecologic
Oncology: Staging classification for cancer of the ovary, fallopian
tube, and peritoneum. Int J Gynaecol Obstet. 124:1–5. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Abe A, Furumoto H, Irahara M, Ino H,
Kamada M, Naka O, Sasaki M, Kagawa T, Okitsu O and Kushiki N: The
impact of systematic para-aortic and pelvic lymphadenectomy on
survival in patients with optimally debulked ovarian cancer. J
Obstet Gynaecol Res. 36:1023–1030. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
duBois A, Reuss A, PujadeLauraine E,
Harter P, RayCoquard I and Pfisterer J: Role of surgical outcome as
prognostic factor in advanced epithelial ovarian cancer: A combined
exploratory analysis of 3 prospectively randomized phase 3
multicenter trials: By the arbeitsgemeinschaft gynaekologische
onkologie studiengruppe ovarialkarzinom (AGO-OVAR) and the groupe
d'investigateurs nationaux pour les etudes des cancers de l'Ovaire
(GINECO). Cancer. 115:1234–1244. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wimberger P, Lehmann N, Kimmig R, Burges
A, Meier W and Du Bois A: Arbeitsgemeinschaft Gynaekologische
Onkologie Ovarian Cancer Study Group: Prognostic factors for
complete debulking in advanced ovarian cancer and its impact on
survival. An exploratory analysis of a prospectively randomized
phase III study of the Arbeitsgemeinschaft gynaekologische
onkologie ovarian cancer study group (AGOOVAR). Gynecol Oncol.
106:69–74. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Aletti GD, Dowdy S, Podratz KC and Cliby
WA: Role of lymphadenectomy in the management of grossly apparent
advanced stage epithelial ovarian cancer. Am J Obstet Gynecol.
195:1862–1868. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
diRe F, Baiocchi G, Fontanelli R, Grosso
G, Cobellis L, Raspagliesi F and di Re E: Systematic pelvic and
paraaortic lymphadenectomy for advanced ovarian cancer: Prognostic
significance of node metastases. Gynecol Oncol. 62:360–365. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Carnino F, Fuda G, Ciccone G, Iskra L,
Guercio E, Dadone D and Conte PF: Significance of lymph node
sampling in epithelial carcinoma of the ovary. Gynecol Oncol.
65:467–472. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kim HS, Ju W, Jee BC, Kim YB, Park NH,
Song YS, Kim SC, Kang SB and Kim JW: Systematic lymphadenectomy for
survival in epithelial ovarian cancer: A meta-analysis. Int J
Gynecol Cancer. 20:520–528. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Onda T, Yoshikawa H, Yasugi T, Mishima M,
Nakagawa S, Yamada M, Matsumoto K and Taketani Y: Patients with
ovarian carcinoma upstaged to stage III after systematic
lymphadenctomy have similar survival to Stage I/II patients and
superior survival to other Stage III patients. Cancer.
83:1555–1560. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Harter P, Gnauert K, Hils R, Lehmann TG,
FisselerEckhoff A, Traut A and du Bois A: Pattern and clinical
predictors of lymph node metastases in epithelial ovarian cancer.
Int J Gynecol Cancer. 17:1238–1244. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Balbi G, Manganaro MA, Monteverde A,
Landino I, Franzese C and Gioia F: Ovarian cancer:
Lymphnodemetastases. Eur J Gynaecol Oncol. 30:289–291.
2009.PubMed/NCBI
|
|
16
|
Suh DH, Kim TH, Kim JW, Kim SY, Kim HS,
Lee TS, Chung HH, Kim YB, Park NH and Song YS: Improvements to the
FIGO staging for ovarian cancer: Reconsideration of lymphatic
spread and intraoperative tumor rupture. J Gynecol Oncol.
24:352–358. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Bakkar R, Gershenson D, Fox P, Vu K,
Zenali M and Silva E: Stage IIIC ovarian/peritoneal serous
carcinoma: A heterogeneous group of patients with different
prognoses. Int J Gynecol Pathol. 33:302–308. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kim HS, Ju W, Jee BC, Kim YB, Park NH,
Song YS, Kim SC, Kang SB and Kim JW: Systematic lymphadenectomy for
survival in epithelial ovarian cancer: A meta-analysis. Int J
Gynecol Cancer. 20:520–528. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Scarabelli C, Gallo A, Visentin MC,
Canzonieri V, Carbone A and Zarrelli A: Systematic pelvic and
para-aortic lymphadenectomy in advanced ovarian cancer patients
with no residual intraperitoneal disease. Int J Gynecol Cancer.
7:18–26. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chang SJ, Bristow RE and Ryu HS: Analysis
of para-aortic lymphadenectomy up to the level of the renal vessels
in apparent early-stage ovarian cancer. J Gynecol Oncol. 24:29–36.
2013. View Article : Google Scholar : PubMed/NCBI
|
